New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
07:00 EDTDVA, FMSFresenius Medical shares should be bought, says Bernstein
Bernstein notes that Fresenius' (FMS) stock has sharply underperformed versus its competitor, DaVita (DVA), since May 2012. But the firm predicts that Fresenius' core U.S. business should outperform that of DaVita going forward. Bernstein adds that it finds Fresenius' business units aside from its U.S. dialysis clinics more attractive than DaVita's businesses other than its U.S. dialysis clinics.
News For FMS;DVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:58 EDTFMSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:03 EDTFMSFresenius Medical upgraded to Neutral from Underweight at HSBC
Subscribe for More Information
February 23, 2015
08:05 EDTDVACMS releases preliminary Medicare Advantage rates for 2016
Subscribe for More Information
February 19, 2015
07:06 EDTFMSFresenius Medical reports data on DHR pilot, plans expansion
Subscribe for More Information
February 17, 2015
17:29 EDTDVABerkshire Hathaway gives quarterly update on stakes, exits Exxon Mobil
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use